International Congress of Parkinson's Disease and Movement Disorders®LikeFollowShareA First in Human Study of PBT434, a Novel Small Molecule Inhibitor of Alpha-Synuclein Aggregationhttps://www.mdsabstracts.org/abstract/a-first-in-human-study-of-pbt434-a-no...Share your feedbackQuestions (0)Post questionYour question will be sent privately to Alterity Therapeutics. The company may choose to make this question public.Start the conversationAsk Alterity Therapeutics a question about this update.DiscoverShare your feedbackDiscover